Penn National Gaming Set to Join S&P SmallCap 600 PR Newswire NEW YORK, March 22, 2017 NEW YORK, March 22, 2017 /PRNewswire/ -- Penn National Gaming Inc. (NASD: PENN) will replace Cynosure...
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cynosure, Inc. - CYNO PR Newswire NEW YORK, Feb. 28, 2017 NEW YORK, Feb. 28, 2017 /PRNewswire/ -- Juan Monteverde...
Harwood Feffer LLP Announces Investigation of Cynosure, Inc. PR Newswire NEW YORK, Feb. 15, 2017 NEW YORK, Feb. 15, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating...
Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses -Expands Hologic's Scientific and...
Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year PR Newswire WESTFORD, Mass., Feb. 7, 2017 WESTFORD, Mass., Feb. 7, 2017...
Cynosure to Host Fourth-Quarter 2016 Financial Results Conference Call on February 7 PR Newswire WESTFORD, Mass., Jan. 6, 2017 WESTFORD, Mass., Jan. 6, 2017 /PRNewswire/ -- Cynosure, Inc...
Cynosure Recognized Among Deloitte's 2016 Technology Fast 500™ PR Newswire WESTFORD, Mass., Dec. 5, 2016 WESTFORD, Mass., Dec. 5, 2016 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today...
Cynosure Receives CFDA Clearance to Market the Icon™ Aesthetic System in China State-of-the-Art Product Enables Aesthetic Practices to Offer the Most Popular Non-Invasive Skin Treatments in a...
Cynosure to Participate in Stifel 2016 Healthcare Conference Fireside Chat to be Webcast Live at 8:00 a.m. (ET) Wednesday, November 16 PR Newswire WESTFORD, Mass., Nov. 10, 2016 WESTFORD, Mass...
Cynosure Promotes Doug Delaney to Chief Commercial Officer Company's Executive VP of Worldwide Sales Expands Leadership Role PR Newswire WESTFORD, Mass., Nov. 1, 2016 WESTFORD, Mass., Nov. 1...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales